COHR

Coherent Inc.

Price

$290.31

return (12m)

194.94%

p/e

114.66

p/bv

4.88

DIVIDEND YIELD

0.00%

COHR price

Coherent

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment COHR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-23.85%

3 months

-13.62%

1 year

194.94%

2 years

296.92%

5 years

330.72%

10 years

1,335.73%

Fundamentals COHR

Valuation

P/E

114.66

Sector -2.25

Industry 8.38

P/BV

4.88

Sector 2.19

Industry 3.48

P/Revenue (PSR)

8.14

Sector 2.02

Industry 3.44

EV/EBITDA

150.71

Sector -25.25

Industry 37.41

EV/EBIT

238.20

Sector -37.87

Industry -23.45

P/EBITDA

43.84

Sector -0.06

Industry 7.81

P/EBIT

75.71

Sector -2.02

Industry 7.67

P/Total Assets

3.11

Sector 1.18

Industry 1.37

P/Ativo Circ. Liq.

308.64

Sector -10.50

Industry -2.17

P/Cap.Giro

12.41

Sector 0.13

Industry -6.28

EPS

2.47

Sector -0.92

Industry 0.05

BVPS

57.98

Sector 3.93

Industry 8.68

Efficiency

Gross Margin

36.78%

Sector 44.22%

Industry 54.39%

EBITDA Margin

20.04%

Sector -312.86%

Industry -8.93%

EBIT Margin

12.68%

Sector -193.59%

Industry -21.42%

Operating Margin

11.24%

Sector -25.72%

Industry -3.69%

Net Profit Margins

7.10%

Sector -30.17%

Industry -7.51%

Giro Ativos

0.10

Sector 0.12

Industry 0.12

Profitability

ROE

4.26%

Sector -34.36%

Industry -15.35%

ROA

2.71%

Sector -28.49%

Industry -3.96%

ROIC

6.93%

Sector -439.00%

Industry -13.19%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.05

Sector 1.88

Industry 2.66

Dívida Líquida/EBITDA

2.12

Sector -1.67

Industry 9.32

Dívida Líquida/EBIT

3.35

Sector -0.92

Industry 8.06

Dívida Líquida/Patrimônio

0.07

Sector -0.35

Industry -0.04

Dívida Bruta/Patrimônio

0.29

Sector 0.15

Industry 0.37

Equity/Assets

0.64

Sector 0.43

Industry 0.48

Liabilities/Assets

0.36

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

15.64%

Sector -

Industry -

5Y Earnings CAGR

8.94%

Sector -

Industry -

FAIR VALUE OF Coherent ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$290.31

Fair Value

$56.76

Upside Return potential.

-80.45%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals COHR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
COHR	114.66	4.88	4.26%	0.00%	$53.76 B	7.10%
ISRG	39.67	6.81	17.15%	0.00%	$124.53 B	28.45%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.50 B	13.20%
BSX	18.45	2.54	13.78%	0.00%	$65.78 B	17.29%
TMDX	14.70	5.12	34.80%	0.00%	$2.53 B	27.04%
RMD	19.01	4.45	23.41%	1.20%	$28.89 B	27.44%
IDXX	41.21	29.00	70.38%	0.00%	$45.13 B	24.63%
SYK	36.85	5.35	14.52%	1.07%	$122.99 B	13.21%
PHG	22.75	1.95	8.56%	3.75%	$25.71 B	5.50%
INMD	11.26	1.48	13.18%	0.00%	$981.23 M	23.27%
DXCM	31.60	9.94	31.47%	0.00%	$29.40 B	19.31%
EW	45.55	4.82	10.58%	0.00%	$49.78 B	17.34%
BDX	39.08	1.84	4.72%	2.37%	$44.47 B	5.33%
IMRA	63.76	1.11	1.74%	0.00%	$100.10 M	0.00%
BDXB	8.75	0.54	6.12%	0.00%	$13.76 B	8.36%
ALGN	27.86	2.89	10.36%	0.00%	$11.97 B	10.50%
ABMD	64.27	11.14	17.32%	0.00%	$17.15 B	24.84%
SNN	12.69	2.49	19.61%	2.52%	$13.16 B	8.66%
ZBH	23.50	1.41	6.00%	1.05%	$17.89 B	9.05%
IRMD	53.18	12.75	23.97%	1.28%	$1.26 B	27.36%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

COHR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	12/17/2012	12/27/2012	1.00000000

ABOUT Coherent

Coherent Inc.

Average Investor10 user rating

4.0 (22 people)

United States

60 years

Founded: 1966

1990

Time since IPO - 36 years

4.875

Employees

Coherent Inc. (United States) is listed on the Nasdaq and has a market capitalization of $53.76 billion, with shareholders equity totaling $11.02 billion.

The company employs approximately 4.875 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Coherent Inc. reported $6.60 billion in revenue, generating net income of $468.85 million.

Key financial metrics include a P/E ratio of 114.66, a price-to-book (P/B) ratio of 4.88, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker COHR.

Market cap

$53.76 billion

Net worth

$11.02 billion

$11,015,690,000.00

Assets

$17.29 billion

$17,286,700,000.00

Total Shares Outstanding

190.00 million

190,000,000

Average Daily Trading Volume

$5.98 million

$5,983,656.00

Sector

Health

Industry

Medical Supplies and Equipment

COHR

revenue by Business Segment Coherent

Revenue by Region Coherent

COHR revenue and profits

Financial Results COHR

DRAG THE FRAME TO SEE MORE DATA

COHR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$107.64 91,06% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$288.18 0,20% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$63.51 137,33% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$394.56 74,63% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$43.41 --9,99% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$1,201.79 49,15% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$385.14 13,53% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$155.45 34,91% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56